American College of Rheumatology

There was an unfortunate series of letters involving the ACR – among them are communications from the American College of Rheumatology (ACR) to FDA and between ACR and URL Pharma. Finally, there is a statement of facts from FDA regarding Colcrys and unapproved colchicine. We regret the need to publish these letters in sequence here but we feel compelled to do so to correct the record for those who are interested in investigating this matter further. A complete reading of this set of letters is quite enlightening.